Brett Ewald

2.1k total citations
19 papers, 897 citations indexed

About

Brett Ewald is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Brett Ewald has authored 19 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Brett Ewald's work include DNA Repair Mechanisms (4 papers), RNA Interference and Gene Delivery (4 papers) and Cancer Research and Treatments (3 papers). Brett Ewald is often cited by papers focused on DNA Repair Mechanisms (4 papers), RNA Interference and Gene Delivery (4 papers) and Cancer Research and Treatments (3 papers). Brett Ewald collaborates with scholars based in United States, Canada and Australia. Brett Ewald's co-authors include William Plunkett, Deepa Sampath, Mark McEvoy, John Attia, Johan Baeck, Chaomei Liu, Kingsley Agho, John Hall, Pamela S. Becker and John Rediske and has published in prestigious journals such as Blood, Cancer Research and Oncogene.

In The Last Decade

Brett Ewald

19 papers receiving 881 citations

Peers

Brett Ewald
Kent Armeson United States
Tarek H. Mouhieddine United States
Della Makower United States
Zohreh Sanaat Iran
Maddalena Raia Italy
Mary Beth Tombes United States
Pantea Izadi Iran
Sha Ma China
Sabine Weber Germany
Yuki Yuza Japan
Kent Armeson United States
Brett Ewald
Citations per year, relative to Brett Ewald Brett Ewald (= 1×) peers Kent Armeson

Countries citing papers authored by Brett Ewald

Since Specialization
Citations

This map shows the geographic impact of Brett Ewald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett Ewald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett Ewald more than expected).

Fields of papers citing papers by Brett Ewald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett Ewald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett Ewald. The network helps show where Brett Ewald may publish in the future.

Co-authorship network of co-authors of Brett Ewald

This figure shows the co-authorship network connecting the top 25 collaborators of Brett Ewald. A scholar is included among the top collaborators of Brett Ewald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett Ewald. Brett Ewald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Dunn, Erica H., et al.. (2022). Community science reveals biennial irruptive migration in the White-breasted Nuthatch (Sitta carolinensis). Journal of Field Ornithology. 93(2). 1 indexed citations
2.
Ewald, Brett, et al.. (2020). Abstract 6713: Oncolytic adenoviruses expressing immune modulators enhance tumor cell killing in human cancer 3D microtumor models. Cancer Research. 80(16_Supplement). 6713–6713. 1 indexed citations
3.
4.
Fueyo, Juàn, Candelaria Gomez‐Manzano, Jaime Rodriguez‐Canales, et al.. (2017). ATIM-08. IMMUNOMARKERS IN THE DNX-2401 (DELTA-24-RGD) ONCOLYTIC VIRUS PHASE I CLINICAL TRIAL. Neuro-Oncology. 19(suppl_6). vi27–vi27. 3 indexed citations
5.
Ewald, Brett, Chaomei Liu, Melanie Sulda, et al.. (2016). HDAC Inhibition Induces MicroRNA-182, which Targets RAD51 and Impairs HR Repair to Sensitize Cells to Sapacitabine in Acute Myelogenous Leukemia. Clinical Cancer Research. 22(14). 3537–3549. 53 indexed citations
6.
7.
Agho, Kingsley, John Hall, & Brett Ewald. (2014). Determinants of the knowledge of and attitude towards tuberculosis in Nigeria.. PubMed. 32(3). 520–38. 30 indexed citations
8.
9.
Fanale, Michelle A., Sarit Assouline, John Kuruvilla, et al.. (2013). Phase IA/II, multicentre, open‐label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non‐Hodgkin or Hodgkin lymphoma. British Journal of Haematology. 164(2). 258–265. 58 indexed citations
10.
Bensinger, William, Richard T. Maziarz, Sundar Jagannath, et al.. (2012). A phase 1 study of lucatumumab, a fully human anti‐CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma. British Journal of Haematology. 159(1). 58–66. 89 indexed citations
11.
Sampath, Deepa, et al.. (2011). Killing of Chronic Lymphocytic Leukemia by the Combination of Fludarabine and Oxaliplatin Is Dependent on the Activity of XPF Endonuclease. Clinical Cancer Research. 17(14). 4731–4741. 7 indexed citations
12.
McEvoy, Mark, Wayne Smith, Catherine D’Este, et al.. (2010). Cohort Profile: The Hunter Community Study. International Journal of Epidemiology. 39(6). 1452–1463. 91 indexed citations
13.
Freedman, Arnold S., John Kuruvilla, Sarit Assouline, et al.. (2010). Clinical Activity of Lucatumumab (HCD122) In Patients (pts) with Relapsed/Refractory Hodgkin or Non-Hodgkin Lymphoma Treated In a Phase Ia/II Clinical Trial (NCT00670592). Blood. 116(21). 284–284. 11 indexed citations
14.
Ewald, Brett, Deepa Sampath, & William Plunkett. (2008). Nucleoside analogs: molecular mechanisms signaling cell death. Oncogene. 27(50). 6522–6537. 181 indexed citations
15.
Sampath, Deepa, George A. Calin, Vinay K. Puduvalli, et al.. (2008). Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation. Blood. 113(16). 3744–3753. 70 indexed citations
16.
Ewald, Brett, Mark McEvoy, & John Attia. (2008). Pedometer counts superior to physical activity scale for identifying health markers in older adults. British Journal of Sports Medicine. 44(10). 756–761. 38 indexed citations
17.
Ewald, Brett, Deepa Sampath, & William Plunkett. (2008). ATM and the Mre11-Rad50-Nbs1 Complex Respond to Nucleoside Analogue–Induced Stalled Replication Forks and Contribute to Drug Resistance. Cancer Research. 68(19). 7947–7955. 36 indexed citations
18.
Ewald, Brett, Deepa Sampath, & William Plunkett. (2007). H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation. Molecular Cancer Therapeutics. 6(4). 1239–1248. 167 indexed citations
19.
Thư, Le Thi Anh, et al.. (2005). Incidence of surgical site infections and accompanying risk factors in Vietnamese orthopaedic patients. Journal of Hospital Infection. 60(4). 360–367. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kent Armeson Breakdown of academic impact, for papers by Tarek H. Mouhieddine Breakdown of academic impact, for papers by Della Makower Breakdown of academic impact, for papers by Zohreh Sanaat Breakdown of academic impact, for papers by Maddalena Raia Breakdown of academic impact, for papers by Mary Beth Tombes Breakdown of academic impact, for papers by Pantea Izadi Breakdown of academic impact, for papers by Sha Ma Breakdown of academic impact, for papers by Sabine Weber Breakdown of academic impact, for papers by Yuki Yuza
Rankless by CCL
2026